Time-action profile of the long-acting insulin analogue insulin glargine in comparison to NPH insulin in Japanese volunteers
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier in Diabetes & Metabolism
- Vol. 29 (4) , 430-431
- https://doi.org/10.1016/s1262-3636(07)70055-1
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Basal Insulin Therapy in Type 2 DiabetesDiabetes Care, 2001
- Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.Diabetes Care, 2000
- Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.Diabetes Care, 2000
- Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.Diabetes Care, 2000
- Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.Diabetes Care, 2000